Fourth quarter revenues were $6.3 million, up 32% over the same quarter in the prior year. PATTERSON, N.J., March 23, 2020 – BrainsWay...

BrainsWay Announces Positive Data from Smoking Cessation Multicenter Study Evaluating Use of Deep TMS at Society for Research on Nicotine...

PATTERSON, N.J., March 04, 2020 – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay”), a global leader in the advanced non-invasive...

Lushi also to serve on Company’s audit committee PATTERSON, N.J., Feb. 10, 2020 – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay”), a...

BrainsWay Reports Results of Interim Analysis of H7 Deep Transcranial Magnetic Stimulation Study in Post-Traumatic Stress Disorder...

BrainsWay Announces Data from Feasibility Study of Deep Transcranial Magnetic Stimulation System in the treatment of Adults with ADHD...

BrainsWay Announces Successful Results in Pivotal Multicenter Study Evaluating Deep Transcranial Magnetic Stimulation System as an Aid in...

Third quarter revenues were $5.9 million, up 38% over the same quarter in the prior year JERUSALEM, Israel and HACKENSACK, N.J., Nov. 25,...

BrainsWay Appoints Medical Technology Industry Leader Christopher R. von Jako, Ph.D., as President and Chief Executive Officer JERUSALEM...

BrainsWay‘s New Stimulator for Deep Transcranial Magnetic Stimulation Makes German Debut at the 2019 German Association for Psychiatry,...

BrainsWay Announces Innovative Deep Transcranial Magnetic Stimulation System Showcase Presentation at this Year’s Psych Congress Meeting...

Company Intends to Appoint U.S.-Based CEO JERUSALEM and HACKENSACK, N.J., Sept. 19, 2019 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ &...

Company also announces changes to U.S. Management Team JERUSALEM, Israel and HACKENSACK, N.J., August 26, 2019 – BrainsWay Ltd. (NASDAQ &...

Groundbreaking Study Demonstrates Advantages of BrainsWay Deep TMS in Treating Major Depressive Disorder First head-to-head, randomized...

New Data Published in American Journal of Psychiatry Further Substantiates BrainsWay’s Deep TMS System for the Treatment of Patients with...

BrainsWay Announces Shipment of 100th Deep Transcranial Magnetic Stimulation Helmet for the Treatment of Obsessive-Compulsive Disorder...

JERUSALEM and HACKENSACK, N.J., June 13, 2019 – BrainsWay Ltd. (NASDAQ & TASE:BWAY) (BrainsWay” or the “Company”), a commercial stage...

More than 260 participants have been enrolled to the study JERUSALEM, Israel and HACKENSACK, N.J., May 22, 2019- BrainsWay Ltd. (NASDAQ &...

JERUSALEM, Israel, April 16, 2019 – BrainsWay Ltd. (NASDAQ: BWAY and TASE:BRIN) (“BrainsWay”) today announced that it has priced its...

Full-Year 2018 revenues of $16.4 million increased 47% over full-year 2017 Fourth quarter revenues of $4.8 million, up 32% over the...